Harrow Announces $100 Million Secured Credit Facility With Oaktree

By Staff
Wednesday, March 29, 2023 12:15 AM NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced that it has entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management, L.P. The interest-only secured credit facility carries an interest rate equal to the three-month secured overnight financing rate (SOFR) plus 6.50 percent, includes flexible terms and covenants, and is expected to mature in approximately three years.

Harrow Announces Q4 and Year-End 2022 Financial Results

By Staff
Monday, March 27, 2023 12:24 AM NASHVILLE, Tenn.—Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended Dec. 31, 2022. The company reported fourth-quarter net income of $1.1 million, after reporting a loss in the same period a year earlier. It posted revenue of $20.3 million in the period. For the year, Harrow reported that its loss narrowed to $14.1 million. Revenue was reported as $88.6 million, up 22 percent over full-year 2021 revenues of $72.5 million.

Safilo Board Approves 2022 Financial Results and Group's Medium-Term Targets

By Staff
Friday, March 10, 2023 12:24 AM PADUA, Italy—The Board of Directors of Safilo Group S.p.A. (SFLG.MI) approved the company’s consolidated financial statements for the year ended Dec. 31, 2022 and examined the separate financial statements for the year ended Dec. 31, 2022, which will be submitted for approval by the shareholders at the annual general meeting to be held in a single call on April 27. The board of directors has decided not to propose the payment of a dividend to the next annual general meeting.

CooperCompanies Post Strong Q1 2023 Results

By Staff
Friday, March 3, 2023 12:33 AM SAN RAMON, Calif.—CooperCompanies (NYSE: COO) announced late yesterday financial results for its fiscal first quarter ended Jan. 31, 2023. Revenue increased 9 percent year-over-year to $858.5 million. CooperVision (CVI) revenue increased 4 percent to $581.3 million, and CooperSurgical (CSI) revenue was up 23 percent to $277.2 million. Commenting on the results, Al White, Cooper's president and CEO said, "We started the year on a positive note with double-digit organic revenue growth and strong operational performances at both CooperVision and CooperSurgical.

Citing Economic 'Headwinds' for its Customer Base, National Vision Holdings, Inc. Reported Q4 Earnings Drop, Sales Dip for the Year

By Staff
Thursday, March 2, 2023 12:27 AM DULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE)  reported its financial results for the fourth quarter and fiscal year ended December 31, 2022, and provided its outlook for fiscal 2023. For the fourth quarter, revenue decreased 1.9 percent to $468.9 million compared to the fourth quarter of 2021. Comparable store sales growth was negative 5.7 percent for the quarter and adjusted comparable store sales growth was down 2.4 percent. For the fiscal year, the company reported net revenue decreased 3.6 percent to $2.01 billion compared to fiscal year 2021.

Warby Parker Reports Full Year Revenue of $598.1 Million, Reduced Losses for Fiscal 2022

By Staff
Wednesday, March 1, 2023 12:30 AM NEW YORK—Warby Parker Inc. (NYSE: WRBY) announced financial results for the fourth quarter and full year ended Dec. 31, 2022. The company reported full year net revenue increased $57.3 million, or 10.6 percent, to $598.1 million compared to full year 2021. Fourth quarter net revenue increased $13.6 million, or 10.2 percent, to $146.5 million compared to fourth quarter 2021. Warby said its active customers increased 3.6 percent to 2.28 million year over year while average revenue per customer increased 6.9 percent year over year to $263.

Alcon Reports Q4 and Year-End Sales Gains

By Staff
Tuesday, February 28, 2023 12:24 AM GENEVA, Switzerland—Alcon (SIX/NYSE:ALC), a global leader in eyecare, reported its financial results for the three and 12 months ended December 31, 2022. For the fourth quarter of 2022, sales were $2.2 billion, an increase of 1 percent on a reported basis and 7 percent on a constant currency basis, as compared to the same quarter of the previous year. Sales for the full year 2022 were $8.7 billion, an increase of 5 percent on a reported basis and 11 percent on a constant currency basis, compared to the full year 2021.

EssilorLuxottica Reports a Record Fiscal Year for 2022, With Increases in All Business Sectors and Geographies

By Staff
Friday, February 24, 2023 12:33 AM MILAN—Characterizing fiscal 2022 as a "year of records" in sales, operating and net profit for the group, senior executives of EssilorLuxottica (Reuters: ESLX.PA) reported that its year-end sales had reached €24.5 billion in fiscal year 2022, up 13.9 percent vs 2021 in comparable term. The group’s comparable-store sales were up 7.7 percent for the 12-month fiscal period, while ex-GrandVision outperformed with its sales rising 9.3 percent, according to an announcement from the company.

Bausch + Lomb Reports Q4 Loss, $6 Million Profit Gain for Full-Year 2022

By Staff
Thursday, February 23, 2023 12:30 AM VAUGHAN, Ontario—Bausch + Lomb Corporation, (NYSE/TSX: BLCO), a leading global eye health company, reported a net loss of $1 million for the fourth-quarter of 2022, after reporting a profit in the same period a year earlier, while the company reported a profit of $6 million for the full-year 2022. Total reported revenues were $996 million for the fourth quarter of 2022, as compared to $1.001 billion in the fourth quarter of 2021, a decrease of $5 million.

Kering Eyewear Sales for Fiscal 2022 Exceed €1.0 Billion, Per Kering Group Year-End Report

By Staff
Thursday, February 16, 2023 12:21 AM PARIS—Kering Group, which includes Kering Eyewear, reported a strong Group performance for the fourth quarter and fiscal year 2022, noting substantial increases on the top lines for its Kering Eyewear business.

VSP Vision Releases Inaugural Social Responsibility Impact Report

By Staff
Thursday, February 16, 2023 12:18 AM RANCHO CORDOVA, Calif.—VSP Vision has released its 2022 Impact Report, which spotlights key initiatives undertaken by the organization in alignment with its decades-long commitment to social responsibility.

1847 Holdings Closes ICU Eyewear Acquisition

By Staff
Tuesday, February 14, 2023 12:18 AM NEW YORK—1847 Holdings announced yesterday that it has completed the acquisition of ICU Eyewear Holdings Inc., a leading designer of over-the-counter (OTC), non-prescription reading glasses, sunglasses, blue light blocking eyewear, sun readers and outdoor specialty sunglasses.

Carl Zeiss Meditec Achieves Q1 Revenue Growth, While Earnings Decline for the Period

By Staff
Monday, February 13, 2023 12:21 AM JENA, Germany—Carl Zeiss Meditec, a manufacturer of optical systems, reported revenue of €470.3 million in the first quarter of fiscal year 2022/23, corresponding to growth of 14.6 percent.

Cohn Eye Center, R&E Optical Join Ascend Vision Partners

By Staff
Friday, February 10, 2023 12:24 AM ORLANDO—Ascend Vision Partners (AVP) has announced the acquisition of Cohn Eye Center and R&E Optical, adding two more premier vision groups to its partnership portfolio. “We are privileged to have partnered with such an outstanding group,” said Chad Tomlinson, chief development officer at Ascend Vision Partners. “Founded by Dr. Richard Cohn, Cohn Eye Center and R&E Optical set the standard for eyecare in Central Florida. I know that together we will continue to build a best-in-class vision platform.” Ascend Vision Partners currently has 11 practices with 19 total locations across the Southeast.

Safilo Group Reports Preliminary Full Year 2022 Performance Indicators

By Staff
Monday, January 30, 2023 12:18 AM PADUA, Italy—The Board of Directors of Safilo Group S.p.A. has reviewed the Group’s preliminary key performance indicators for the financial year ended Dec. 31, 2022 and the full year annual results will be approved by the Board of Directors on March 9, 2023.